Harbour BioMed and Otsuka Enter $670M+ Global Agreement Across Asia, US, and Europe to Advance Bispecific T-Cell Engager for Autoimmune Diseases

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology ...

June 23, 2025 | Monday | News
Draig Therapeutics Launches with $140M to Advance Novel Neuropsychiatric Treatments

Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric disorders with a rich pipeline of ...

June 19, 2025 | Thursday | News
SynaptixBio Advances First Clinical Candidate for Rare H-ABC Disease With Promising Antisense Oligonucleotide Therapy

SynaptixBio, the only company licensed to commercialise a treatment for a rare, deadly disease, says the drug could halt disease progression and even rever...

June 11, 2025 | Wednesday | News
Agenus and Zydus Forge Strategic Partnership to Advance BOT/BAL Immunotherapy and Launch BioCDMO Operations in the U.S.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifescienc...

June 05, 2025 | Thursday | News
Conduit Pharmaceuticals and Manoira Partner to Advance Cross-Species Glucokinase Activator Programs in $15B Animal Health Market

Collaboration leverages cutting-edge reformulation expertise to generate cross-species insights, fast-track human clinical programs, and seeks to captu...

June 05, 2025 | Thursday | News
BioAge Labs Expands Obesity Pipeline With APJ Agonist Advances and JiKang Therapeutics Option Deal

BioAge Labs, Inc. ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by t...

June 04, 2025 | Wednesday | News
Astellas Inks $1.54 Billion Licensing Deal with Evopoint for ADC Candidate XNW27011 Targeting CLDN18.2

- Agreement grants Astellas exclusive worldwide rights (excluding China's mainland, Hong Kong, Macao and Taiwan region) to develop and commercialize XNW2...

May 30, 2025 | Friday | News
Alvotech and Advanz Pharma Expand Biosimilars Partnership with Three New Candidates in Europe

Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a U...

May 29, 2025 | Thursday | News
Sanofi Completes $600M Acquisition of DR-0201, Expanding Immunology Pipeline with First-in-Class Myeloid Cell Engager

 Sanofi announces the completion of its acquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private...

May 28, 2025 | Wednesday | News
GlycoEra Secures $130M Series B to Advance First-in-Class IgG4 Protein Degrader Into Clinical Trials

Financing led by Novo Holdings with significant support from world-class group of existing and new investors Proceeds from financing to support developm...

May 28, 2025 | Wednesday | News
Angelini Ventures Joins $39M Series A Extension to Advance Therini Bio’s Alzheimer’s and DME Therapy

Angelini Ventures joins top-tier investor syndicate Investment will fund Phase 1b studies evaluating Therini Bio’s lead candidate, THN391, for ...

May 15, 2025 | Thursday | News
QIAGEN Acquires Genoox for $70M to Expand AI-Powered Genomic Interpretation Portfolio

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insigh...

May 13, 2025 | Tuesday | News
LENZ Therapeutics and Lotus Pharmaceutical Ink $125M Licensing Deal to Commercialize LNZ100 for Presbyopia in Asia

LENZ Therapeutics, Inc.  and Lotus Pharmaceutical Co., Ltd. y announced an exclusive license and commercialization agreement for Lotus to commercial...

May 12, 2025 | Monday | News
Addex Therapeutics and Sinntaxis Partner to Advance Dipraglurant for Brain Injury Recovery

Addex Therapeutics  a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neu...

May 01, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close